Axonics Investor Relations Material
Latest events
Q3 2023
Axonics
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Axonics Inc
Access all reports
Axonics Inc is a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder dysfunction. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention.
Key slides for Axonics Inc
Investor Presentation
Axonics Inc
Investor Presentation
Axonics Inc
Latest articles
Remembering Daniel Kahneman: Transforming Psychology and Economics
Explore Daniel Kahneman's legacy in psychology and economics, highlighting his impact on decision-making and behavioral economics.
28 Mar 2024
Deere & Company: Shaping Agriculture & Construction Since 1837
Exploring Deere & Company: A global leader in agriculture & construction equipment since 1837.
28 Mar 2024
Jane Fraser: First Female Leader of a Major Wall Street Bank
Discover the journey of Jane Fraser, CEO of Citigroup and the first female leader of a major Wall Street bank.
28 Mar 2024
Ticker symbol
Country
🇺🇸 United States